We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARVL
9326
PUT
DELISTED
Arrival Ordinary Shares
ARVL
$356K ﹤0.01%
4,504
-2,690
-37% -$284K
VIVO
9327
PUT
DELISTED
Meridian Bioscience Inc
VIVO
$356K ﹤0.01%
11,700
-6,800
-37% -$184K
EYE icon
9328
CALL
National Vision
EYE
$1.53B
$355K ﹤0.01%
12,900
+7,200
+126% +$237K
NDLS icon
9329
Noodles & Co
NDLS
$107M
$355K ﹤0.01%
9,439
+7,933
+527% +$352K
ROOT icon
9330
CALL
Root
ROOT
$797M
$355K ﹤0.01%
16,594
-212
-1% -$5.74K
CTRE icon
9331
CALL
CareTrust REIT
CTRE
$9.16B
$354K ﹤0.01%
19,200
+2,300
+14% +$40.8K
CXM icon
9332
CALL
Sprinklr
CXM
$1.61B
$354K ﹤0.01%
35,000
-12,700
-27% -$154K
RDNT icon
9333
PUT
RadNet
RDNT
$6.01B
$354K ﹤0.01%
20,500
-15,800
-44% -$307K
SEV
9334
CALL
DELISTED
Sono Group N.V. Common Shares
SEV
$354K ﹤0.01%
120,400
-18,700
-13% -$72.5K
DURA icon
9335
VanEck Durable High Dividend ETF
DURA
$39.5M
$353K ﹤0.01%
11,683
+4,423
+61% +$139K
GYRE icon
9336
CALL
Gyre Therapeutics
GYRE
$708M
$353K ﹤0.01%
26,427
+9,254
+54% +$61.5K
SRRK icon
9337
CALL
Scholar Rock
SRRK
$6.4B
$353K ﹤0.01%
64,300
-19,400
-23% -$139K
TTEC icon
9338
CALL
TTEC Holdings
TTEC
$77.9M
$353K ﹤0.01%
5,200
+1,300
+33% +$91.3K
SCPX
9339
CALL
DELISTED
Scorpius Holdings, Inc.
SCPX
$353K ﹤0.01%
35
-10
-22% -$100K
AWI icon
9340
CALL
Armstrong World Industries
AWI
$7.7B
$352K ﹤0.01%
4,700
-400
-8% -$33.8K
EFAX icon
9341
State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF
EFAX
$518M
$352K ﹤0.01%
+10,742
New +$380K
ISPO
9342
CALL
DELISTED
Inspirato
ISPO
$352K ﹤0.01%
+3,800
New +$438K
ADAM
9343
PUT
Adamas Trust
ADAM
$910M
$352K ﹤0.01%
31,850
-128,600
-80% -$1.58M
SIVR icon
9344
CALL
abrdn Physical Silver Shares ETF
SIVR
$4.37B
$352K ﹤0.01%
18,100
-11,600
-39% -$252K
TCPC icon
9345
CALL
BlackRock TCP Capital
TCPC
$342M
$352K ﹤0.01%
28,100
+6,600
+31% +$88.7K
VRM icon
9346
Vroom Inc
VRM
$56.8M
$352K ﹤0.01%
3,518
-12,129
-78% -$1.52M
RTL
9347
PUT
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$352K ﹤0.01%
48,300
-32,900
-41% -$248K
SRRA
9348
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$352K ﹤0.01%
6,406
-461,403
-99% -$24.2M
ARR
9349
PUT
Armour Residential REIT
ARR
$2.37B
$351K ﹤0.01%
9,960
+1,100
+12% +$40.8K
ASMB icon
9350
Assembly Biosciences
ASMB
$671M
$351K ﹤0.01%
13,914
+12,204
+714% +$281K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.